Peter P. Pfreundschuh

2019 - UroGen Pharma Ltd.

In 2019, Peter P. Pfreundschuh earned a total compensation of $1.3M as Chief Financial Officer at UroGen Pharma Ltd., a 46% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$261,375
Option Awards$436,108
Salary$435,625
Stock Awards$212,500
Other$1,183
Total$1,346,791

Pfreundschuh received $436.1K in option awards, accounting for 32% of the total pay in 2019.

Pfreundschuh also received $261.4K in non-equity incentive plan, $435.6K in salary, $212.5K in stock awards and $1.2K in other compensation.

Rankings

In 2019, Peter P. Pfreundschuh's compensation ranked 7,861st out of 13,971 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 43.7% of executives.

ClassificationRankingPercentile
All
7,861
out of 13,971
44th
Division
Manufacturing
3,095
out of 5,701
46th
Major group
Chemicals And Allied Products
1,167
out of 2,200
47th
Industry group
Drugs
997
out of 1,886
47th
Industry
Pharmaceutical Preparations
740
out of 1,398
47th

Pay ratio

Peter P. Pfreundschuh's Pay$1,346,791
Median Employee's Pay$223,867
Pay Ratio

6

to 1

In 2019, the annual total compensation of Peter P. Pfreundschuh was $1,346,791.

The annual total compensation of the median employee at UroGen Pharma Ltd. was $223,867.

The ratio of Peter P. Pfreundschuh's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 29, 2020.

Pfreundschuh's colleagues

We found four more compensation records of executives who worked with Peter P. Pfreundschuh at UroGen Pharma Ltd. in 2019.

2019

Elizabeth Barrett

UroGen Pharma Ltd.

Chief Executive Officer

2019

Stephen Mullennix

UroGen Pharma Ltd.

Chief Operating Officer

2019

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

2019

Ron Bentsur

UroGen Pharma Ltd.

Chief Executive Officer

News

You may also like